H.C. Wainwright analyst Emily Bodnar reiterated a Neutral rating target on Ventyx Biosciences Inc (NASDAQ: VTYX).The analyst commented: "Ventyx announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE